Association Between Sleep Duration and Albuminuria in Patients with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Li, Xueyu
Chattopadhyay, Kaushik
Qian, Xingjun
Yu, Jingjia
Xu, Miao
Li, Li
Sun, Jing
Li, Jialin
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2022
Size
File type(s)
Location
Abstract

Purpose: Type 2 diabetes mellitus (T2DM) can lead to microvascular complications including diabetic kidney disease. Albuminuria is an important marker to diagnose kidney injury in T2DM patients and healthy sleep duration is important for maintaining good health in patients with T2DM. However, the association between sleep duration and albuminuria in T2DM patients is unclear. Thus, this study aimed to investigate the association between sleep duration and albuminuria in patients with T2DM in Ningbo, China. Methods: A cross-sectional study was conducted at National Metabolic Management Centre (MMC)- Ningbo First Hospital from March 2018 to February 2021. Adult patients with T2DM were included in the study. The sleep duration (daytime and nocturnal) was self-reported. Albuminuria was defined as the presence of urinary albumin-creatinine ratio ≥30 mg/g. Logistic regression analyses were performed to identify the association. Results: There were 2688 T2DM patients in the study. In the unadjusted model (1), the odds of albuminuria increased with the daytime sleep duration (31–60 minutes: OR 1.36, 95% CI 1.09–1.71; ≥61 minutes: 1.73, 1.33–2.24). Similarly, after adjusting for age and sex (model 2), the odds of albuminuria increased with the daytime sleep duration (31–60 minutes: 1.34, 1.07–1.68; ≥61 minutes: 1.69, 1.30–2.20). After adjusting for age, sex, physical activity, smoking, alcohol drinking, overweight/obesity, hypertension, hyperuricaemia, duration of T2DM, glycated haemoglobin, angiotensin-converting enzyme inhibitors/angiotensin receptor blocker usage and nocturnal sleep duration (model 3), the odds of albuminuria increased with the daytime sleep duration (31–60 minutes: 1.33, 1.04–1.71; ≥61 minutes: 1.71, 1.29–2.26). However, no relationship was found between nocturnal sleep duration and albuminuria. Conclusion: Longer daytime sleep is found to be associated with albuminuria in patients with T2DM in Ningbo, China but no association is found between nocturnal sleep duration and albuminuria. The findings are exploratory, and there is a need for longitudinal studies on this topic.

Journal Title

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Conference Title
Book Title
Edition
Volume

15

Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2022 Li et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution– Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

Item Access Status
Note
Access the data
Related item(s)
Subject

Medical biochemistry and metabolomics

Clinical sciences

Persistent link to this record
Citation

Li, X; Chattopadhyay, K; Qian, X; Yu, J; Xu, M; Li, L; Sun, J; Li, J, Association Between Sleep Duration and Albuminuria in Patients with Type 2 Diabetes: A Cross-Sectional Study in Ningbo, China, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, pp. 1667-1675

Collections